BridgeMD
Tests treatment safety and results for Yellow Fever Vaccine
Official title VAC-SIP-YF (Vaccination- Safety & Immunogenicity During Pregnancy- Yellow Fever)
ClinicalTrials.gov ID: NCT06694766
What this study is testing
- What it's testing
- The aim of this study is to compare the immunogenicity induced by yellow fever vaccination administered during pregnancy with that induced by vaccination outside pregnancy, and to assess the maternal and fetal tolerance of this vaccination.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only. Healthy volunteers may be eligible.
You may be able to join if
- Common :
- Person over 18 years of age at the time of the first yellow fever vaccination
- Female gender
- Oral consent obtained after subject has been informed
- Subject covered by Social Security with the exception of Aide Médicale d'Etat Specific to both groups :
You likely can't join if
- Criteria common to both sections (tolerance and immunogenicity):
- Subject having received a second yellow fever vaccination
- Persons unable to give informed consent for participation
- Women born in areas where yellow fever is endemic
- Female adults under legal protection (guardianship or trusteeship) Specific criteria for participants in the immunogenicity section:
- Medical condition imcompatible with 18.5 mL blood
See the full eligibility criteria
- Common :
- Person over 18 years of age at the time of the first yellow fever vaccination
- Female gender
- Oral consent obtained after subject has been informed
- Subject covered by Social Security with the exception of Aide Médicale d'Etat Specific to both groups :
- For women vaccinated during pregnancy (case): Primary yellow fever vaccination during pregnancy
- For women vaccinated outside pregnancy (control): Primary yellow fever vaccination outside pregnancy
- Criteria common to both sections (tolerance and immunogenicity):
- Subject having received a second yellow fever vaccination
- Persons unable to give informed consent for participation
- Women born in areas where yellow fever is endemic
- Female adults under legal protection (guardianship or trusteeship) Specific criteria for participants in the immunogenicity section:
- Medical condition imcompatible with 18.5 mL blood
- Women who have not given written consent to participate in the study. immunogenicity
The study team makes the final eligibility decision.
Where it's taking place
- Paris, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Paris, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.